Cargando…

Cotargeting Plk1 and androgen receptor enhances the therapeutic sensitivity of paclitaxel-resistant prostate cancer

BACKGROUNDS: Despite the clinical success of taxanes, they still have limitations, such as chemoresistance. To overcome the limitations of paclitaxel, genetic alterations and targeting effects of altered genes were observed in paclitaxel-resistant cancer. Because paclitaxel-resistant cancer shows hi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Sol-Bi, Woo, Sang-Uk, Yim, Hyungshin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515847/ https://www.ncbi.nlm.nih.gov/pubmed/31156720 http://dx.doi.org/10.1177/1758835919846375

Ejemplares similares

Combination of Inhibitors of USP7 and PLK1 has a Strong Synergism against Paclitaxel Resistance
por: Shin, Sol-Bi, et al.
Publicado: (2020)

Dual Targeting of EGFR with PLK1 Exerts Therapeutic Synergism in Taxane-Resistant Lung Adenocarcinoma by Suppressing ABC Transporters
por: Shin, Sol-Bi, et al.
Publicado: (2021)

PICH and Cotargeted Plk1 Coordinately Maintain Prometaphase Chromosome Arm Architecture
por: Kurasawa, Yasuhiro, et al.
Publicado: (2010)

PLK1-mediated phosphorylation of β-catenin enhances its stability and transcriptional activity for extracellular matrix remodeling in metastatic NSCLC
por: Kim, Da-Eun, et al.
Publicado: (2023)

Active PLK1-driven metastasis is amplified by TGF-β signaling that forms a positive feedback loop in non-small cell lung cancer
por: Shin, Sol-Bi, et al.
Publicado: (2019)

Correction: Active PLK1-driven metastasis is amplified by TGF-β signaling that forms a positive feedback loop in non-small cell lung cancer
por: Shin, Sol-Bi, et al.
Publicado: (2019)

PLK1/vimentin signaling facilitates immune escape by recruiting Smad2/3 to PD-L1 promoter in metastatic lung adenocarcinoma
por: Jang, Hay-Ran, et al.
Publicado: (2021)

Correction: PLK1/vimentin signaling facilitates immune escape by recruiting Smad2/3 to PD-L1 promoter in metastatic lung adenocarcinoma
por: Jang, Hay-Ran, et al.
Publicado: (2021)

Plk2-mediated phosphorylation and translocalization of Nrf2 activates anti-inflammation through p53/Plk2/p21(cip1) signaling in acute kidney injury
por: Kim, Da-Eun, et al.
Publicado: (2022)

Cotargeting among microRNAs in the brain
por: Cherone, Jennifer M., et al.
Publicado: (2019)

Computational Peptide Design Cotargeting Glucagon and Glucagon-like Peptide-1 Receptors
por: Vishnoi, Shubham, et al.
Publicado: (2023)

Plk1 is upregulated in androgen-insensitive prostate cancer cells and its inhibition leads to necroptosis
por: Deeraksa, Arpaporn, et al.
Publicado: (2012)

Cotargeting of XPO1 Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Acute Myeloid Leukemia
por: Brinton, Lindsey T., et al.
Publicado: (2020)

Synergistic anti-tumor activity and inhibition of angiogenesis by cotargeting of oncogenic and death receptor pathways in human melanoma
por: Grazia, G, et al.
Publicado: (2014)

Production of wax esters in plant seed oils by oleosomal cotargeting of biosynthetic enzymes
por: Heilmann, Mareike, et al.
Publicado: (2012)

A New Compound with Increased Antitumor Activity by Cotargeting MEK and Pim-1
por: Li, Yanan, et al.
Publicado: (2020)

Systematic characterization of seed overlap microRNA cotargeting associated with lupus pathogenesis
por: Kitai, Hiroki, et al.
Publicado: (2022)

Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies
por: Jacob, Aasems, et al.
Publicado: (2021)

A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells
por: Li, Tzu-Huey, et al.
Publicado: (2007)

Enhancing the Therapeutic Efficacy of KRAS(G12C) Inhibitors in Lung Adenocarcinoma Cell Models by Cotargeting the MAPK Pathway or HSP90
por: Liu, Ying, et al.
Publicado: (2021)

Integrative Gene Expression Profiling Reveals That Dysregulated Triple microRNAs Confer Paclitaxel Resistance in Non-Small Cell Lung Cancer via Cotargeting MAPT [Corrigendum]
Publicado: (2020)

Cotargeting of CYP-19 (aromatase) and emerging, pivotal signalling pathways in metastatic breast cancer
por: Daldorff, Stine, et al.
Publicado: (2017)

MicroRNA-5110 regulates pigmentation by cotargeting melanophilin and WNT family member 1
por: Yang, Shanshan, et al.
Publicado: (2018)

Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphoma
por: Jiang, Vivian Changying, et al.
Publicado: (2023)

Androgen receptor signaling is required for androgen-sensitive human prostate cancer cell proliferation and survival
por: Yang, Qing, et al.
Publicado: (2005)

Invasive FoxM1 phosphorylated by PLK1 induces the polarization of tumor-associated macrophages to promote immune escape and metastasis, amplified by IFITM1
por: Xu, Rong, et al.
Publicado: (2023)

Androgen Receptor as a Driver of Therapeutic Resistance in Advanced Prostate Cancer
por: Kahn, Barbara, et al.
Publicado: (2014)

Therapeutic targeting of the androgen receptor (AR) and AR variants in prostate cancer
por: Narayanan, Ramesh
Publicado: (2020)

Analyzing the Androgen Receptor Interactome in Prostate Cancer: Implications for Therapeutic Intervention
por: Dahiya, Ujjwal R., et al.
Publicado: (2022)

Biological and Clinical Significance of Androgens and Androgen Receptor in Prostate Cancer
por: Koochekpour, Shahriar
Publicado: (2014)

Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cells
por: Levina, Elina, et al.
Publicado: (2015)

Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target
por: Asim, Mohammad, et al.
Publicado: (2015)

Response to BRAF-targeted Therapy Is Enhanced by Cotargeting VEGFRs or WNT/β-Catenin Signaling in BRAF-mutant Colorectal Cancer Models
por: Tran, Khanh B., et al.
Publicado: (2022)

Therapeutic androgen receptor ligands
por: Allan, George F., et al.
Publicado: (2003)

Plasma Androgen Receptor in Prostate Cancer
por: Conteduca, Vincenza, et al.
Publicado: (2019)

Loss of FBXW7 and accumulation of MCL1 and PLK1 promote paclitaxel resistance in breast cancer
por: Gasca, Jessica, et al.
Publicado: (2016)

Simultaneous cotargeting of ATR and RNA Polymerase I transcription demonstrates synergistic antileukemic effects on acute myeloid leukemia
por: Wang, Tingting, et al.
Publicado: (2019)

Invariant NKT cells dictate antitumor immunity elicited by a bispecific antibody cotargeting CD3 and BCMA
por: Casey, Mika, et al.
Publicado: (2022)

Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer
por: Nardi, Francesca, et al.
Publicado: (2023)

Registered report: androgen receptor splice variants determine taxane sensitivity in prostate cancer
por: Shan, Xiaochuan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sion7havqu3q0i6n736mn1d81i